Myconom Biomaterials
PrivateLast Round
Grant
Feb 26, 2024
Total Funding Raised
$153,600
Company Overview
Myconom Biomaterials operates in Energy & Sustainability and is based in Turkey. Its latest recorded funding round was a Grant round in February 2024.
Myconom Biomaterials is a biotechnology company that develops biodegradable composite materials using mushroom mycelium and agricultural waste as sustainable alternatives to plastic and petroleum-based products.
Sector
Energy & Sustainability
Verticals
Sustainable Materials, Circular Economy, Biotechnology, Construction Tech, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myconom Biomaterials Comparables
Compare Myconom Biomaterials with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MycoLutions GmbH | 90% | |
| MycoFab | 89% | |
| Taftirium | 86% |
For institutional investors. Book with your work email.
Myconom Biomaterials Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 26, 2024 | ||||
| Grant | Dec 8, 2022 |
For institutional investors. Book with your work email.
Myconom Biomaterials Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| İTÜ Çekirdek | Grant |
| Global Cleantech Innovation Programme | Grant |
| Türkiye Bilimsel ve Teknolojik Araştırma Kurumu | Grant |
| United Nations Industrial Development Organization | Grant |
| Sabancı ARF | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 256% MoM.
For institutional investors. Book with your work email.
Myconom Biomaterials Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Myconom Biomaterials's valuation, stock price, and market status.
Is Myconom Biomaterials a public or private company?
Myconom Biomaterials is a private company.
What is the current stock price of Myconom Biomaterials?
Myconom Biomaterials is a private company, so its shares have no public market price. Caplight tracks Myconom Biomaterials's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Myconom Biomaterials worth (valuation)?
Valuation information for Myconom Biomaterials is not publicly available.
Can I buy Myconom Biomaterials stock?
Myconom Biomaterials shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Myconom Biomaterials's last funding round?
Myconom Biomaterials's most recent funding round was Grant on February 26, 2024.
Who are the main investors in Myconom Biomaterials?
Key investors in Myconom Biomaterials include Sabancı ARF.
Will Myconom Biomaterials IPO soon?
No public IPO plans have been announced for Myconom Biomaterials.
How can I track Myconom Biomaterials secondary market activity?
Caplight tracks bids, offers, and trades in Myconom Biomaterials's shares on secondary markets.